NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NINDS E-101-2012-1-UA-19 DIHYDROXYPHENYL NEUROTRANSMITTER COMPOUNDS, COMPOSITIONS AND METHODS UA National Stage a201600974 Pending
NICHD E-120-2015-0-US-20 Method For On-demand Contraception US CON 15/016,845 10159681 Issued PDF
NCI E-494-2013-0-CN-05 Methods of Preparing Anti-human Papillomavirus Antigen T Cells CN National Stage 201480044285.7 Issued
NCI E-494-2013-0-RU-08 Methods of Preparing Anti-human Papillomavirus Antigen T Cells RU National Stage 2016103614 Issued
NCI E-495-2013-0-CN-05 Anti-Human Papillomavirus 16 E6 T Cell Receptors CN National Stage 201480044286.1 Issued
NCI E-293-2010-0-US-04 Lipopeptide Inhibitors Of RAS Oncoprotein US DIV 15/015,940 Abandoned
NINDS E-101-2012-1-EA-09 DIHYDROXYPHENYL NEUROTRANSMITTER COMPOUNDS, COMPOSITIONS AND METHODS EA National Stage 201600093 Pending
NCI E-066-2016-0-US-01 Fulvestrant Improves Immune-mediated Cytotoxic Lysis Of Cancer Cells US 62/290,117 Abandoned
NCI E-508-2013-2-BR-03 M971 INHIBITORS OF THE FARNESOID X RECEPTOR AND USES IN MEDICINE BR National Stage BR112016002268-8 Abandoned
NCI E-508-2013-2-NZ-09 INHIBITORS OF THE FARNESOID X RECEPTOR AND USES IN MEDICINE NZ National Stage 716568 Abandoned
NCI E-508-2013-2-JP-08 INHIBITORS OF THE FARNESOID X RECEPTOR AND USES IN MEDICINE JP National Stage 2016-531936 Abandoned
NCI E-080-2008-0-US-05 Human Monoclonal Antibodies Specific for CD22 US DIV 15/012,023 9598492 Issued PDF
NCI E-508-2013-2-US-10 Inhibitors of the Farnesoid X Receptor and Uses in Medicine US National Stage 14/909,263 9540415 Abandoned PDF
NCI E-276-2014-0-PCT-02 Methods and Kits For Measuring and Quantifying DNA Double-Stranded Breaks Using Gamma-H2AX and H2AX PCT PCT PCT/US2016/016000 Expired
NIAID E-257-2015-0-US-01 Compounds for Modulating FceRIB Expression and Uses Thereof US 62/289,447 Abandoned
NCI E-048-2010-0-US-05 Agonist/Antagonist Compositions and Methods of Use US CON 15/010,830 Abandoned
NIAID E-020-2018-0-PCT-02 CYTOMEGALOVIRUS-BASED VACCINE EXPRESSING EBOLA VIRUS GLYCOPROTEIN PCT PCT PCT/EP16/051854 Expired
NIAID E-021-2019-0-JP-05 CONFORMATIONALLY-STABILIZED RSV PREFUSION F PROTEIN JP National Stage 2016-530055 Issued
NINDS E-030-2013-0-BE-05 11-OXO-10,11-Dihydrodibenzo[B,F][1,4]Thiazepine S-Oxide Derivatives And Their Use As Dopamine D2 Receptor Antagonists BE EP 14750663.8 Issued
NINDS E-030-2013-0-IE-10 11-OXO-10,11-Dihydrodibenzo[B,F][1,4]Thiazepine S-Oxide Derivatives And Their Use As Dopamine D2 Receptor Antagonists IE EP 14750663.8 Issued
NINDS E-030-2013-0-DE-07 11-OXO-10,11-Dihydrodibenzo[B,F][1,4]Thiazepine S-Oxide Derivatives And Their Use As Dopamine D2 Receptor Antagonists DE EP 14750663.8 Issued
NINDS E-030-2013-0-FR-08 11-OXO-10,11-Dihydrodibenzo[B,F][1,4]Thiazepine S-Oxide Derivatives And Their Use As Dopamine D2 Receptor Antagonists FR EP 14750663.8 Issued
NINDS E-030-2013-0-CH-06 11-OXO-10,11-Dihydrodibenzo[B,F][1,4]Thiazepine S-Oxide Derivatives And Their Use As Dopamine D2 Receptor Antagonists CH EP 14750663.8 Issued
NINDS E-030-2013-0-GB-09 11-OXO-10,11-Dihydrodibenzo[B,F][1,4]Thiazepine S-Oxide Derivatives And Their Use As Dopamine D2 Receptor Antagonists GB EP 14750663.8 Issued
NIAID E-142-2008-0-US-05 HUMANIZED MONOCLONAL ANTIBODIES THAT SPECIFICALLY BIND AND/OR NEUTRALIZE JAPANESE ENCEPHALITIS VIRUS (JEV) AND THEIR USE US DIV 15/004,795 9783596 Abandoned PDF
NCI E-292-2014-0-PCT-02 Hydrogels and Use Thereof in Anastomosis Procedures PCT PCT PCT/US2016/014534 Expired
NCI E-171-2018-2-US-01 NON-VIRAL MODIFIED CELLS AND METHODS OF THERAPY US 62/286,206 Abandoned
E-125-2017-0-US-01 CRYSTAL STRUCTURE OF CRISPR CPF1 US 62/281,947 Abandoned
NCI E-292-2014-0-EP-03 Hydrogels and Use Thereof in Anastomosis Procedures EP National Stage 16703211.9 Abandoned
NIAID E-125-2008-0-US-05 MONOCLONAL ANTIBODIES THAT REACT WITH THE CAPSULE OF BACILLUS ANTHRACIS US DIV 15/003,719 9845350 Abandoned PDF
NIAID E-241-2014-0-GB-01 Recombinant Human/Bovine Parainfluenza Virus 3 (B/HPIV3) Expressing a Chimeric RSV/BPIV3 F Protein and Uses Thereof GB EP 16702318.3 Issued
NIAID E-241-2014-0-EP-05 Recombinant Human/Bovine Parainfluenza Virus 3 (B/HPIV3) Expressing a Chimeric RSV/BPIV3 F Protein and Uses Thereof EP National Stage 16702318.3 Issued
NIAID E-241-2014-0-TR-01 Recombinant Human/Bovine Parainfluenza Virus 3 (B/HPIV3) Expressing a Chimeric RSV/BPIV3 F Protein and Uses Thereof TR EP 16702318.3 Issued
NIAID E-241-2014-0-CH-01 Recombinant Human/Bovine Parainfluenza Virus 3 (B/HPIV3) Expressing a Chimeric RSV/BPIV3 F Protein and Uses Thereof CH EP 16702318.3 Issued
NIAID E-241-2014-0-ES-01 Recombinant Human/Bovine Parainfluenza Virus 3 (B/HPIV3) Expressing a Chimeric RSV/BPIV3 F Protein and Uses Thereof ES EP 16702318.3 Issued
NIAID E-241-2014-0-SE-01 Recombinant Human/Bovine Parainfluenza Virus 3 (B/HPIV3) Expressing a Chimeric RSV/BPIV3 F Protein and Uses Thereof SE EP 16702318.3 Issued
NIAID E-241-2014-0-BE-01 Recombinant Human/Bovine Parainfluenza Virus 3 (B/HPIV3) Expressing a Chimeric RSV/BPIV3 F Protein and Uses Thereof BE EP 16702318.3 Issued
NIAID E-241-2014-0-AT-01 Recombinant Human/Bovine Parainfluenza Virus 3 (B/HPIV3) Expressing a Chimeric RSV/BPIV3 F Protein and Uses Thereof AT EP 16702318.3 Issued
NIAID E-241-2014-0-LU-01 Recombinant Human/Bovine Parainfluenza Virus 3 (B/HPIV3) Expressing a Chimeric RSV/BPIV3 F Protein and Uses Thereof LU EP 16702318.3 Issued
NIAID E-241-2014-0-LT-01 Recombinant Human/Bovine Parainfluenza Virus 3 (B/HPIV3) Expressing a Chimeric RSV/BPIV3 F Protein and Uses Thereof LT EP 16702318.3 Issued
NIAID E-241-2014-0-IT-01 Recombinant Human/Bovine Parainfluenza Virus 3 (B/HPIV3) Expressing a Chimeric RSV/BPIV3 F Protein and Uses Thereof IT EP 16702318.3 Issued
NIAID E-241-2014-0-BG-01 Recombinant Human/Bovine Parainfluenza Virus 3 (B/HPIV3) Expressing a Chimeric RSV/BPIV3 F Protein and Uses Thereof BG EP 16702318.3 Issued
NIAID E-241-2014-0-HR-01 Recombinant Human/Bovine Parainfluenza Virus 3 (B/HPIV3) Expressing a Chimeric RSV/BPIV3 F Protein and Uses Thereof HR EP 16702318.3 Issued
NIAID E-241-2014-0-CZ-01 Recombinant Human/Bovine Parainfluenza Virus 3 (B/HPIV3) Expressing a Chimeric RSV/BPIV3 F Protein and Uses Thereof CZ EP 16702318.3 Issued
NIAID E-241-2014-0-DK-01 Recombinant Human/Bovine Parainfluenza Virus 3 (B/HPIV3) Expressing a Chimeric RSV/BPIV3 F Protein and Uses Thereof DK EP 16702318.3 Issued
NIAID E-241-2014-0-FI-01 Recombinant Human/Bovine Parainfluenza Virus 3 (B/HPIV3) Expressing a Chimeric RSV/BPIV3 F Protein and Uses Thereof FI EP 16702318.3 Issued
NIAID E-241-2014-0-FR-01 Recombinant Human/Bovine Parainfluenza Virus 3 (B/HPIV3) Expressing a Chimeric RSV/BPIV3 F Protein and Uses Thereof FR EP 16702318.3 Issued
NIAID E-241-2014-0-EE-01 Recombinant Human/Bovine Parainfluenza Virus 3 (B/HPIV3) Expressing a Chimeric RSV/BPIV3 F Protein and Uses Thereof EE EP 16702318.3 Issued
NIAID E-241-2014-0-RO-01 Recombinant Human/Bovine Parainfluenza Virus 3 (B/HPIV3) Expressing a Chimeric RSV/BPIV3 F Protein and Uses Thereof RO EP 16702318.3 Issued
NIAID E-241-2014-0-SI-01 Recombinant Human/Bovine Parainfluenza Virus 3 (B/HPIV3) Expressing a Chimeric RSV/BPIV3 F Protein and Uses Thereof SI EP 16702318.3 Issued